Entrada Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 08/14/2026 | 5.07 M | $37.34 M | 0.00% | 12.01% |
| 5AM VENTURE MANAGEMENT, LLC | 08/14/2026 | 4.06 M | $29.85 M | 0.00% | 9.61% |
| BLACKROCK, INC. | 08/07/2026 | 2.58 M | $19.01 M | 9.52% | 6.12% |
| MERCK & CO., INC. | 08/07/2026 | 1.74 M | $12.80 M | 100.00% | 4.12% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.27 M | $9.34 M | 1.08% | 3.01% |
| BIOIMPACT CAPITAL LLC | 08/14/2026 | 1.25 M | $9.22 M | 100.00% | 2.97% |
| TCG CROSSOVER MANAGEMENT, LLC | 08/14/2026 | 1.06 M | $7.80 M | -53.65% | 2.51% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 954.42 K | $7.02 M | -7.77% | 2.26% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 763.96 K | $5.62 M | 47.10% | 1.81% |
| STEPSTONE GROUP LP | 08/13/2026 | 761.28 K | $5.60 M | 0.00% | 1.80% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 717.43 K | $5.28 M | 7.50% | 1.70% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 699.54 K | $5.15 M | 780.00% | 1.66% |
| STATE STREET CORP | 08/07/2026 | 596.68 K | $4.39 M | 11.78% | 1.41% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 542.32 K | $3.99 M | 3.09% | 1.28% |
| JPMORGAN CHASE & CO | 08/12/2026 | 496.46 K | $3.83 M | 3,243.82% | 1.18% |
| ACADIAN ASSET MANAGEMENT LLC | 08/13/2026 | 400.86 K | $2.95 M | 20.32% | 0.95% |
| CITADEL ADVISORS LLC | 09/02/2026 | 394.32 K | $2.90 M | 83.39% | 0.93% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 376.14 K | $2.77 M | 15.92% | 0.89% |
| NORTHERN TRUST CORP | 08/13/2026 | 309.94 K | $2.28 M | 31.89% | 0.73% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2026 | 303.46 K | $2.23 M | -9.12% | 0.72% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 08/19/2026 | 300.58 K | $2.21 M | 88.65% | 0.71% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 254.13 K | $1.87 M | 15.25% | 0.60% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 197.14 K | $1.45 M | -8.20% | 0.47% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 197.14 K | $1.45 M | 100.00% | 0.47% |
| LONGAEVA PARTNERS L.P. | 08/14/2026 | 195.24 K | $1.44 M | -4.75% | 0.46% |
| MORGAN STANLEY | 08/13/2026 | 191.65 K | $1.41 M | 8.81% | 0.45% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 191.00 K | $1.41 M | -5.48% | 0.45% |
| QUANTINNO CAPITAL MANAGEMENT LP | 08/13/2026 | 188.84 K | $1.39 M | 165.90% | 0.45% |
| LYNX1 CAPITAL MANAGEMENT LP | 08/13/2026 | 178.61 K | $1.31 M | -15.63% | 0.42% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 177.34 K | $1.31 M | -16.65% | 0.42% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 167.65 K | $1.23 M | 6.88% | 0.40% |
| WOODLINE PARTNERS LP | 08/14/2026 | 145.60 K | $1.07 M | -32.59% | 0.34% |
| TREXQUANT INVESTMENT LP | 08/14/2026 | 140.14 K | $1.03 M | 69.39% | 0.33% |
| MOORE CAPITAL MANAGEMENT, LP | 08/14/2026 | 105.00 K | $772.80 K | 0.00% | 0.25% |
| XTX TOPCO LTD | 08/14/2026 | 95.34 K | $701.68 K | -26.42% | 0.23% |
| BNP PARIBAS ARBITRAGE, SNC | 08/13/2026 | 95.04 K | $699.52 K | -47.53% | 0.23% |
| ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 08/13/2026 | 93.54 K | $688.44 K | 380.54% | 0.22% |
| GSA CAPITAL PARTNERS LLP | 08/06/2026 | 88.01 K | $648.00 K | 100.00% | 0.21% |
| ROYCE & ASSOCIATES LP | 08/14/2026 | 82.90 K | $610.16 K | -31.40% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 08/12/2026 | 79.70 K | $586.60 K | 2.22% | 0.19% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 79.07 K | $581.96 K | 3.46% | 0.19% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 09/09/2026 | 72.52 K | $533.75 K | 2.64% | 0.17% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 70.40 K | $518.11 K | 0.16% | 0.17% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2026 | 60.87 K | $448.02 K | -30.39% | 0.14% |
| CANTOR FITZGERALD, L. P. | 08/19/2026 | 60.00 K | $441.60 K | 27.66% | 0.14% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 57.93 K | $426.34 K | 47.73% | 0.14% |
| NUVEEN, LLC | 08/11/2026 | 56.78 K | $417.88 K | -67.68% | 0.13% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 08/14/2026 | 54.11 K | $398.27 K | 100.00% | 0.13% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 53.59 K | $394.41 K | 0.00% | 0.13% |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 08/14/2026 | 52.77 K | $388.37 K | 337.28% | 0.13% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Entrada Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 160 institutional investors and hedge funds held shares of Entrada Therapeutics Inc. The most heavily invested institutionals were:
BAKER BROS. ADVISORS LP: 5.07 M
5AM Venture Management, LLC: 4.06 M
BlackRock, Inc.: 2.58 M
Merck & Co., Inc.: 1.74 M
VANGUARD CAPITAL MANAGEMENT LLC: 1.27 M
BioImpact Capital LLC: 1.25 M
69.35% of Entrada Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 37.30 M shares in the last 24 months. This purchase volume represents approximately $473.67 M in transactions.